SEC Form 4 · accession 0001209191-15-039608
Viking Therapeutics, Inc. · VKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rochelle Hanley
Officer — Chief Medical Officer
Period of report
May 4, 2015
Accepted (ET)
May 6, 2015 · 7:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001607678
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per shareF1,F2,F3 | May 4, 2015 | D | 158,453 | — | D | 91,547 | D | |
| Common Stock, par value $0.00001 per share | May 4, 2015 | A | 70,000 | $0.00 | A | 161,547 | D | |
| Common Stock, par value $0.00001 per share | May 4, 2015 | F | 7,308 | $9.49 | A | 168,855 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6 | $9.49 | May 4, 2015 | A | 30,000 | A | May 4, 2015 | May 4, 2025 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Of the shares repurchased by the Issuer, 79,226 shares were fully vested and 79,227 were subject to vesting.
- F2Shares were repurchased by the Issuer at a price of $0.00001 per share.
- F3Includes 45,773 shares of restricted stock that are subject to vesting, of which 22,887 will vest on April 15, 2016 and 22,887 will vest on April 15, 2017.
- F4Represents a restricted stock award of common stock under the Issuer's 2014 Equity Incentive Plan. One third of the shares subject to the restricted stock award shall vest on each one year anniversary of the grant date of the award.
- F5Represents a restricted stock award of 13,974 shares of common stock granted under the Issuer's 2014 Equity Incentive Plan. All of the shares subject to the restricted stock award vested immediately upon grant. In order to satisfy certain tax withholding obligations, the Issuer repurchased 6,666 of these shares from the Reporting Person.
- F625% of the shares subject to the option were vested upon grant and 25% of the shares subject to the option will vest on each one year anniversary of the grant date.